Drug Markets/LAMIVUDINE ORAL

LAMIVUDINE ORAL

1 NDCs across 1 manufacturers|1 Generic,0 Brand

Total NDCs

1G / 0B

Manufacturers

competing in market

Price Spread

$0.24 – $0.24

7d Activity

2↓-1 flat

of 1 total NDCs

Monthly average NADAC price per unit, split by generic and brand

1 manufacturer producing LAMIVUDINE ORAL

1 NDCs total, 1 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
LAMIVUDINE 10 MG/ML ORAL SOLN	62135070637	Chartwell RX LLC	$0.2389 per ML	—	Generic	-4.25%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor